We examined the role of GPM6B in glioma stem cells and found that GPM6B suppressed the sphere-forming capacity of GSCs, accompanied by reduced expression of Wnt pathway–related proteins, including β-catenin, p-STAT3, and c-Myc. Here, GPM6B is linked to central nervous system cancer.